Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes.
Journal: Diabetes care
Published: February 27, 2025
One-Hour Plasma Glucose Predicts the Progression From Normal Glucose Tolerance to Prediabetes.
Journal: Diabetes care
Published: December 20, 2024
Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 18, 2024
The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans.
Journal: Frontiers in physiology
Published: September 27, 2021
Dapagliflozin lowers plasma glucose concentration and improves β-cell function.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 25, 2015
Showing 1-5 of 5
Last Updated: 09/26/2026